Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct;53(10):2041-2049.
doi: 10.1007/s11255-021-02957-w. Epub 2021 Jul 16.

Cystatin C predicts renal function impairment after partial or radical tumor nephrectomy

Mike Wenzel  1   2 , Hang Yu  3 , Annemarie Uhlig  4 , Christoph Würnschimmel  5   6 , Manuel Wallbach  7 , Andreas Becker  8 , Margit Fisch  3 , Felix K H Chun  8 , Christian P Meyer  3 , Marianne Leitsmann  4
Affiliations

Cystatin C predicts renal function impairment after partial or radical tumor nephrectomy

Mike Wenzel et al. Int Urol Nephrol. 2021 Oct.

Abstract

Purpose: To test the value of preoperative and postoperative cystatin C (CysC) as a predictor on kidney function after partial (PN) or radical nephrectomy (RN) in renal cell carcinoma (RCC) patients with normal preoperative renal function.

Methods: From 01/2011 to 12/2014, 195 consecutive RCC patients with a preoperative estimated glomerular filtration rate (eGFR) > 60 ml/min/1.73m2 underwent surgical RCC treatment with either PN or RN. Logistic and linear regression models tested for the effect of CysC as a predictor of new-onset chronic kidney disease in follow-up (eGFR < 60 ml/min/1.73m2). Moreover, postoperative CysC and creatinine values were compared for kidney function estimation.

Results: Of 195 patients, 129 (66.2%) underwent PN. In postoperative and in follow-up setting (median 14 months, IQR 10-20), rates of eGFR < 60 ml/min/1.73m2 were 55.9 and 30.2%. In multivariable logistic regression models, preoperative CysC [odds ratio (OR): 18.3] and RN (OR: 13.5) were independent predictors for a reduced eGFR < 60 ml/min/1.73m2 in follow-up (both p < 0.01), while creatinine was not. In multivariable linear regression models, a difference of the preoperative CysC level of 0.1 mg/dl estimated an eGFR decline in follow-up of about 5.8 ml/min/1.73m2. Finally, we observed a plateau of postoperative creatinine values in the range of 1.2-1.3 mg/dl, when graphically depicted vs. postoperative CysC values ('creatinine blind area').

Conclusion: Preoperative CysC predicts renal function impairment following RCC surgery. Furthermore, CysC might be superior to creatinine for renal function monitoring in the early postoperative setting.

Keywords: Acute kidney injury; Cystatin C; GFR; Nephrectomy; Renal cell carcinoma.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1
Loess plots depicting the relationship between postoperative cystatin c level and postoperative creatinine level in A all examined patients and in B patients with acute kidney injury (AKI) after kidney surgery for renal cell carcinoma
Fig. 2
Fig. 2
Loess plots depicting the relationship between postoperative cystatin c level and postoperative creatinine level in A patients aged ≥ 50 years in B patients aged ≥ 60 years C patients aged ≥ 70 years and D patients aged < 50 years after kidney surgery for renal cell carcinoma
See this image and copyright information in PMC

References

    1. Van Poppel H, Becker F, Cadeddu JA, et al. Treatment of localised renal cell carcinoma. Eur Urol. 2011;60(4):662–672. doi: 10.1016/j.eururo.2011.06.040. - DOI - PubMed
    1. Nocera L, Collà Ruvolo C, Stolzenbach LF, et al. Tumor stage and substage predict cancer-specific mortality after nephrectomy for nonmetastatic renal cancer: histological subtype-specific validation. Eur Urol Focus. 2021 doi: 10.1016/j.euf.2021.02.009. - DOI - PubMed
    1. Würnschimmel C, Ruvolo CC, Nocera L, et al. Race/ethnicity determines life expectancy in surgically treated T1aN0M0 renal cell carcinoma patients. Eur Urol Focus. 2021 doi: 10.1016/j.euf.2021.02.004. - DOI - PubMed
    1. Huang WC, Levey AS, Serio AM, et al. Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. Lancet Oncol. 2006;7(9):735–740. doi: 10.1016/S1470-2045(06)70803-8. - DOI - PMC - PubMed
    1. Thompson RH, Lane BR, Lohse CM, et al. Renal function after partial nephrectomy: effect of warm ischemia relative to quantity and quality of preserved kidney. Urology. 2012;79(2):356–360. doi: 10.1016/j.urology.2011.10.031. - DOI - PubMed